title: Sebaceous glands as the primary target of EGFR-inhibitors in the development of papulopustular eruption.
authors.forename: Tomoya
authors.initials: T
authors.lastname: Takata
authors.forename: Masahito
authors.initials: M
authors.lastname: Tarutani
authors.forename: Christos C
authors.initials: CC
authors.lastname: Zouboulis
authors.forename: Shigetoshi
authors.initials: S
authors.lastname: Sano
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects; D001205:Ascorbic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D002478:Cells, Cultured; D000068818:Cetuximab; D016207:Cytokines / Q000235:genetics / Q000378:metabolism; D003875:Drug Eruptions / Q000209:etiology* / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D015603:Keratinocytes / Q000187:drug effects / Q000473:pathology; D012627:Sebaceous Glands / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D016207:Cytokines; C011669:ascorbate-2-phosphate; D066246:ErbB Receptors; D001205:Ascorbic Acid; D000068818:Cetuximab